BridgeMD
New treatment option for Aerobic Exercise
Official title Arterial Stiffness in Individuals With Breast Cancer
ClinicalTrials.gov ID: NCT07070778
What this study is testing
- What it's testing
- The aim of this study was to evaluate vascular toxicity induced by anthracyclines and other anticancer drugs and to measure arterial stiffness in women with breast cancer and, in addition, to evaluate the acute and chronic arterial stiffness responses of upper extremity aerobic exercise training.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 69, women only
You may be able to join if
- To be between the ages of 40-69,
- Baseline left ventricular ejection fraction (LVEF) \>50%,
- Absence of coronary artery disease and haemodynamically significant valvular heart disease,
- Absence of carotid atherosclerotic plaques,
- Volunteering to participate in the research,
You likely can't join if
- Presence of active infection,
- Presence of bilateral breast cancer,
- History of surgical, neurological or orthopaedic problems that may affect upper extremity functionality other than breast cancer surgery,
- Having a neurological disease or other clinical diagnosis that may affect cognitive status,
- Left ventricular dysfunction and severe liver and kidney dysfunction before starting chemotherapy
- Musculoskeletal and neurological disease that may affect exercise performance, symptomatic heart disease, previous lung surgery and malignant disease.
See the full eligibility criteria
- To be between the ages of 40-69,
- Baseline left ventricular ejection fraction (LVEF) \>50%,
- Absence of coronary artery disease and haemodynamically significant valvular heart disease,
- Absence of carotid atherosclerotic plaques,
- Volunteering to participate in the research,
- At least 15 months after breast cancer surgery,
- No problems in reading and/or understanding the scales and being able to co-operate with the tests.
- Physically inactive (60 minutes of structured exercise per week \<).
- Presence of active infection,
- Presence of bilateral breast cancer,
- History of surgical, neurological or orthopaedic problems that may affect upper extremity functionality other than breast cancer surgery,
- Having a neurological disease or other clinical diagnosis that may affect cognitive status,
- Left ventricular dysfunction and severe liver and kidney dysfunction before starting chemotherapy
- Musculoskeletal and neurological disease that may affect exercise performance, symptomatic heart disease, previous lung surgery and malignant disease.
- Presence of unstable hypertension or diabetes mellitus.
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, State, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 40 years to 69 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, State, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.